Cephalalgia

Article	Citations
Efficacy of different cannabinoid compounds on migraine-like responses in female rats	108
Visual snow vs. migraine aura: Debate summary and novel insights into the syndrome	104
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world	76
Harassment in the headache field: a global web-based cross-sectional survey	74
Corticosteroid-dependent increased expression of CGRP and its receptor subunits within the rodent trigeminal ganglion does not prompt cephalic allodynia	70
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controll	67
Persistent idiopathic facial pain: Integrating headache neurology insights into interdisciplinary guidelines	62
International Classification of Headache Disorders-4 – Work in Progress 1	44
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care	43
Introducing the four dimensions 4D migraine scale: A composite score proposal evaluating migraine severity and treatment efficacy	43
Genetic characterization of the endocannabinoid system and psychiatric features in patients with migraine and medication overuse headache	42
Evidence-based guidelines for the pharmacological treatment of migraine	42
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials	40
Impact of psychiatric comorbidity, resilience and executive function on childhood and adolescent headaches: A narrative review	39
Rethinking migraine with aura: Why cortical spreading depolarization (depression), not aura, causes headaches	38
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization	38
Systemic lupus erythematosus mimicking retinal migraine: a case report	38
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex	35
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study	35
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa	35
Childhood and adolescent headache: A problem not to be ignored in the era of new therapies	34
Depression screening in migraine - A double-edged sword	34
Painful nervus intermedius neuropathy attributed to Bell's palsy: The need for independent diagnostic criteria	33
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”	33
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment	33

Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury	33
IHC 2025 late-breaking abstracts	32
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system	32
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria	31
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study	31
An altered reward system characterizes chronic migraine with medication overuse headache	30
Author response to ‘Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications’	30
COVID-19 vaccination-triggered cluster headache episodes with frequent attacks	30
Effect of Altmetric score on manuscript citations: A randomized-controlled trial	30
Comorbidity or combination – more evidence for cluster-migraine?	30
Sex differences in photophobic behaviors following cortical spreading depression in rats	28
Looking at Cephalalgia from the inside	28
Case reports: Could sexual dysfunction in women with migraine be a side effect of CGRP inhibition?	27
Neck pain in migraine: A narrative review and steps to correct evaluation and treatment	27
Migraine and risk of atrial fibrillation: A 9-year follow-up based on the Trøndelag Health Study	25
Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions	23
Physical impairment during and between migraine attacks: A daily diary study of patients with chronic migraine	23
The midfacial segment pain: little known disorder in need of scientific evaluation	22
Greater occipital nerve block for the treatment of migraine: An umbrella review, systematic review, and meta-analysis	22
Crossing the Rubicon? The future impact of artificial intelligence on headache medicine	22
Genome sequencing reveals the Adgrl3 ( ADGRL3 ) gene as a possible cause of cephalic hypersensitivity in the STA rat and migraine in human	22
Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study	22
Galcanezumab modulates Capsaicin-induced C-fiber reactivity	21
The non-decussating and decussating trigeminothalamic tracts in humans: A combination of connectome-based tractography and histological validation	21
miR-382-5p and miR-34a in migraine: Expression in monocytes and a post-hoc exploratory comparison with expression in peripheral blood mononuclear cells	21
A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants	21
What is the evolutionary disadvantage of migraine?	21
Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks	20
Guidelines Update: Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition – An experience-based update	20
Overlap between perceived triggers, premonitory symptoms and symptom persistence across migraine phases: A REFORM study	20
Real-world efficacy of galcanezumab for the treatment of migraine in Korean patients	20
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition	20
Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®	20
Thanks to Reviewers	19
Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection	19
Involvement of adenosine signaling pathway in migraine pathophysiology: A systematic review of clinical studies	19
Muscae volitantes: A 19th-century precursor of visual snow syndrome?	18
Advancing understanding of migraine pathophysiology and therapy by consideration of patient sex	18
Burden of headache in a HIV-positive population of sub-Saharan Africa	18
Abstracts from the International Headache Congress 14–17 September 2023	18
Plasma adrenomedullin levels in migraine: A registry for migraine (REFORM) study	18
Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review	18
Preclinical and clinical evaluation of LY3451838, a PACAP-neutralizing monoclonal antibody, in randomized, double-blind, placebo-controlled phase 1 and phase 2 studies involving healthy adults and adu	18
The “index vein” as a sign for migraine aura in the emergency setting	18
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society	18
Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process	18
Stroke due to small-vessel disease and migraine: A case–control study of a young adult with ischemic stroke population	17
Internet and social media's role in migraine education: Headache or not headache?	17
Comorbidity with fibromyalgia predicted poorer outcomes in patients with chronic migraine on flunarizine: Prospective proof-of-concept study	17
Abnormal heart rate variability and its application in predicting treatment efficacy in patients with chronic migraine: An exploratory study	17

Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension	17
Shared genetics and causal relationships between migraine and thyroid function traits	17
Effectiveness of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in menstrually-related migraine: The unmet need of perimenstrual headache days	17
Letter to the Editor regarding “Effect of Altmetric score on manuscript citations: A randomized-controlled trial”	17
Erratum	17
Brain imaging in migraine with and without aura: Similarities and differences	17
The impact of eating disorders on idiopathic intracranial hypertension	17
Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention. GRADE tables elaborated by the ad hoc working group of the International Headache Society	16
Premonitory symptoms in migraine: A REFORM Study	16
Are we closer to achieving precision medicine for migraine treatment? A narrative review	16
Corneal confocal microscopy identifies corneal nerve fiber loss in patients with migraine	16
Efficacy of eptinezumab in non-responders to subcutaneous monoclonal antibodies against CGRP and the CGRP receptor: A retrospective cohort study	16
The effect of treatment onset time on acute efficacy in migraine patients treating with remote electrical neuromodulation (REN)	16
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients	16
Cigarette smoking history (personal and secondary childhood exposure) in non-cluster headache trigeminal autonomic cephalalgias: A clinic based study	15
Corrigendum: No structural brain alterations in new daily persistent headache – a cross sectional VBM/SBM study	15
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache	15
Avoidance behaviour modulates but does not condition phonophobia in migraine	15
Longitudinal trajectories of posttraumatic headache after pediatric mild traumatic brain injury	15
Board Walk – April 2022	15
Exploring the association between familial hemiplegic migraine genes (CACNA1A, ATP1A2 and SCN1A) with migraine and epilepsy: A UK Biobank exome-wide association study	15
Reply to “Methodological considerations in assessing the impact of CGRP monoclonal antibodies on blood pressure”	15
Neurological and psychiatric comorbidities of migraine: Concepts and future perspectives	15
Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent he	15
Comment on “Lack of reproducibility of resting-state functional MRI findings in migraine with aura”	14
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study	14
Recurrent Painful Ophthalmoplegic Neuropathy: A case report with atypical features and a review of the literature	14
Proposed general diagnostic criteria for secondary headaches	14
Electrophysiological findings in migraine may reflect abnormal synaptic plasticity mechanisms: A narrative review	14
Prevalence and treatment of typical and atypical headaches in patients with Chiari I malformation: A meta-analysis and literature review	14
Bridging the gaps of headache care for underserved populations: Current status of the headache field in Latin America	14
“Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials	14
New migraine drugs: A critical appraisal of the reason why the majority of migraine patients do not receive an adequate medication	14
Children under 6 years with acute headache in Pediatric Emergency Departments. A 2-year retrospective exploratory multicenter Italian study	14
The clinical outcome of patients starting monoclonal antibodies anti-CGRP with concomitant migraine preventive treatments	14
The long-term effect of work schedule, shift work disorder, insomnia and restless legs syndrome on headache among nurses: A prospective longitudinal cohort study	13
Hypnic Headache – What do we know in 2022?	13
It's not either-or: Why migraine care needs both real-world evidence studies and randomized controlled trials	13
Prevalence of neck pain in migraine: A systematic review and meta-analysis	13
Efficacy and safety of eptinezumab in a predominantly Asian population with chronic migraine: Results of the randomized, double-blind, placebo-controlled SUNRISE trial	13
Mutation screening and association analysis of NOTCH3 p.R544C in patients with migraine with or without aura	13
Headache at the chronic stage of cerebral venous thrombosis	13
Research to improve headache classification: Results, methods, and future challenges	13
Comparison of continuous headache features in youth with migraine, new daily persistent headache, and persistent post-traumatic headache	13
Generative chatbots in headache education and research: A narrative review	12
Adjunctive occipital nerve block for emergency treatment of acute migraine: A randomized, controlled trial	12
Late Breaking Author Index	12
Opening of ATP-sensitive potassium channels activates meningeal nociceptors: Implications for the origin of migraine headache	12
Other primary headaches: Distinct clinical features and uncertain pathophysiology	12
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab	12
Cephalalgia: a legacy of excellence, a vision for tomorrow	12
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review	12
Persistent headache attributed to past cervicocephalic artery dissection: clinical characteristics and contributors to headache persistence	11
Migraine and the risk of stroke in a middle-aged and elderly population: A prospective cohort study	11
How migraine and its associated treatment impact on pregnancy outcomes: Umbrella review with updated systematic review and meta-analysis	11
Comment on ‘'Correlation between endometriosis and migraine features: Results from a prospective case-control study'‘	11
Multidisciplinary headache treatment with work-focus in Norway: An observational study	11
The psychometric properties of an e-headache diary in migraine	11
Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine	11
Epicranial headaches part 2: Nummular headache and epicrania fugax	11
Personal view: Modelling pain mechanisms of migraine without aura	11
Addressing unmet needs in migraine: Real-world fremanezumab effectiveness in participants of the PEARL study with at least three prior preventive treatment failures	11
Oxygen inhalation has no effect on provoked cranial autonomic symptoms using kinetic oscillation stimulation in healthy volunteers	11
Transition of headache care from childhood to adulthood: Focusing needs, barriers, and models of care. A position paper of the IHS Child and Adolescent Committee	11
Orofacial pain for clinicians: A review of constant and attack-like facial pain syndromes	11
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies	11
A need for an expert consensus guideline on performing peripheral nerve blocks in headache patients	11
An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine	11
Recovery and long-term outcome after neurosurgical closure of spinal CSF leaks in patients with spontaneous intracranial hypotension	11
Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports	11
Migraine and risk of hypertensive disorders of pregnancy: A population-based cohort study	10
Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial	10
Migraine and insufficient sleep: The effect of sleep restriction on nociceptive evoked potentials in migraine	10
Lack of a direct link between macular cones function and photophobia in interictal migraine	10
Update in the understanding of new daily persistent headache	10
Reviewing the complex relationship between circadian rhythms and cluster headache	10
Overuse of analgesics can affect the fertility biomarker Anti-Müllerian Hormone in females. A translational study	10
Health care resource utilization and costs associated with diagnosed medication overuse headache and potential acute medication overuse in individuals with migraine	10
Treatment experiences and clinical characteristics in migraine and tension-type headache patients before the first visit to a tertiary headache center	10
Phenotyping non-idiopathic pseudotumor cerebri syndrome – A prospective cohort study	10

Primary headache disorders in adolescents in North- and South-Tyrol: Findings of the EVA-Tyrol-Study	10
It is a long way to the top if you wanna citations?	10
Developing an artificial intelligence-based headache diagnostic model and its utility for non-specialists’ diagnostic accuracy	10
Reaching international consensus on the definition of refractory migraine using the Delphi method	10
The SIH-EBP Score: A grading scale to predict the response to the first epidural blood patch in spontaneous intracranial hypotension	10
Substance P and the trigeminovascular system: From preclinical mechanisms to human headache induction	10
Open label experience of repeated OnabotulinumtoxinA injections towards the sphenopalatine ganglion in patients with chronic cluster headache and chronic migraine	10
Visual snow syndrome is probably not mediated by CGRP: A case series	10
Pathophysiology of cluster headache: From the trigeminovascular system to the cerebral networks	10